As earlier described, alternative ways to explore the progression and/or regression of liver fibrosis and subsequent development of cirrhosis is by targeting the liver with CCL4 [57] or other chemotoxins, such as thioacetamide (TAA) [8,11,12]. The gene discussed is CCL4; the disease is Hepatic fibrosis.